AUTL

Autolus Therapeutics
AUTL

Overview Fund Activity

73 hedge funds and large institutions have $272M invested in Autolus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+14
Holders Change %
+23.73%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
24
Increased
19
Reduced
18
Closed
10
Calls
$754K
Puts
$227K
Net Calls
+$527K
Net Calls Change
-$28K

Top Buyers

1
Blackstone Inc
1
Blackstone Inc
New York
$93.3M
2
NCM
2
Nantahala Capital Management
Connecticut
$21.2M
3
WP
3
Woodline Partners
California
$4.87M
4
BlackRock
4
BlackRock
New York
$2.45M
5
SG Americas Securities
5
SG Americas Securities
New York
$1.3M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$8.81M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$4.42M
3
GIM
3
Granahan Investment Management
Massachusetts
$0
4
SM
4
Sabby Management
Florida
$712K
5
Millennium Management
5
Millennium Management
New York
$1.61M
Name Holding Trade Value Shares
Change 		Shares
Change %
BJL
76
Brighton Jones LLC
Washington
– -$115K -17,560 Closed
ProShare Advisors
77
ProShare Advisors
Maryland
– -$80K -12,192 Closed
PCM
78
Penserra Capital Management
California
– -$8K -1,305 Closed
1 2 3
4